logo
Select company
Select metric
$ -24.59MEarning Before Interest & Taxes (EBIT)
VS
Market
23
Sector
49
Industry
64
History
7
$ 14.15Close
$ 6.7 - $ 682.84 52-Week Range
Ticker Information

Ticker

RNAZ

Company Name

TRANSCODE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TRANSCODE THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAZ - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -24.59M
3/31/2025$ -25.5M
12/31/2024$ -16.73M
9/30/2024$ -14.85M
6/30/2024$ -17.84M
3/31/2024$ -16.99M
12/31/2023$ -18.49M
9/30/2023$ -19.59M
6/30/2023$ -18.58M
3/31/2023$ -18.91M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRANSCODE THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -1.95M.
  • Over the past 5 years, TRANSCODE THERAPEUTICS INC's average EBIT has been $ -15.79M.
  • The median EBIT for TRANSCODE THERAPEUTICS INC during this period was $ -17.28M
  • TRANSCODE THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -1.95M.
  • The lowest EBIT recorded by TRANSCODE THERAPEUTICS INC in the same timeframe $ -25.5M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

RNAZ - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -25.5M

Minimum

Mar 31, 2025

$ -1.95M

Maximum

Dec 31, 2020

$ -15.79M

Average

$ -17.28M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M